Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| Abbott Laboratories (NYSE: ABT) | Delayed: 100.51 -1.94 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.45 | 52 Week High | $46.38 | |||
| Open | $101.31 | 52 Week Low | $36.00 | |||
| Day High | $106.35 | P/E | 67.01 | |||
| Day Low | $97.67 | EPS | $1.50 | |||
| Volume | 22,781,270 | |||||
